ArticleDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2015
[Benign course of diffuse cutaneous mastocytosis with massive blisters].
Article in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiffuse cutaneous mastocytosis is a rare disease with increased numbers of mast cells and development of blisters, which can be easily overlooked. CASE REPORT: A 6-month-old girl was presented by her parents with acute onset of numerous, disseminated bullae on her body. Histology revealed numerous mast cells in a skin sample and highly elevated serum tryptase levels were detected. The diagnosis of diffuse cutaneous mastocytosis was made. The patient was medically treated with glucocorticoids and antibiotics. Within a few years of time a complete remission of developing bullae, a major clinical improvement as well as a continuous decrease of basal tryptase was seen. Today, the girl is 14 years old and without any apparent limitation due to the disease and in fact she is very successful in competitive sports.
conclusionDespite often severe symptoms at first manifestation, this clinical development showing a benign course is typical in children.
Indexed as
Identifiers
25761911What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.